Literature DB >> 31270240

Antigen structure affects cellular routing through DC-SIGN.

Cassie M Jarvis1, Daniel B Zwick2, Joseph C Grim3, Mohammad Murshid Alam1, Lynne R Prost2, Jaye C Gardiner4, Soyeong Park4, Laraine L Zimdars4, Nathan M Sherer4, Laura L Kiessling5,2,3.   

Abstract

Dendritic cell (DC) lectins mediate the recognition, uptake, and processing of antigens, but they can also be coopted by pathogens for infection. These distinct activities depend upon the routing of antigens within the cell. Antigens directed to endosomal compartments are degraded, and the peptides are presented on major histocompatibility complex class II molecules, thereby promoting immunity. Alternatively, HIV-1 can avoid degradation, as virus engagement with C-type lectin receptors (CLRs), such as DC-SIGN (DC-specific ICAM-3-grabbing nonintegrin) results in trafficking to surface-accessible invaginated pockets. This process appears to enable infection of T cells in trans We sought to explore whether antigen fate upon CLR-mediated internalization was affected by antigen physical properties. To this end, we employed the ring-opening metathesis polymerization to generate glycopolymers that each display multiple copies of mannoside ligand for DC-SIGN, yet differ in length and size. The rate and extent of glycopolymer internalization depended upon polymer structure-longer polymers were internalized more rapidly and more efficiently than were shorter polymers. The trafficking, however, did not differ, and both short and longer polymers colocalized with transferrin-labeled early endosomes. To explore how DC-SIGN directs larger particles, such as pathogens, we induced aggregation of the polymers to access particulate antigens. Strikingly, these particulate antigens were diverted to the invaginated pockets that harbor HIV-1. Thus, antigen structure has a dramatic effect on DC-SIGN-mediated uptake and trafficking. These findings have consequences for the design of synthetic vaccines. Additionally, the results suggest strategies for targeting DC reservoirs that harbor viral pathogens.

Entities:  

Keywords:  C-type lectin; HIV; antigen; endocytosis; polymer

Year:  2019        PMID: 31270240      PMCID: PMC6660738          DOI: 10.1073/pnas.1820165116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

1.  DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

Authors:  T B Geijtenbeek; D S Kwon; R Torensma; S J van Vliet; G C van Duijnhoven; J Middel; I L Cornelissen; H S Nottet; V N KewalRamani; D R Littman; C G Figdor; Y van Kooyk
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

Review 2.  C-type lectin receptors on dendritic cells and Langerhans cells.

Authors:  Carl G Figdor; Yvette van Kooyk; Gosse J Adema
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

3.  Overexpression of rab7 enhances the kinetics of antigen processing and presentation with MHC class II molecules in B cells.

Authors:  Edward M Bertram; Robert G Hawley; Tania H Watts
Journal:  Int Immunol       Date:  2002-03       Impact factor: 4.823

Review 4.  Mechanisms of phagocytosis in macrophages.

Authors:  A Aderem; D M Underhill
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

5.  Influencing receptor-ligand binding mechanisms with multivalent ligand architecture.

Authors:  Jason E Gestwicki; Christopher W Cairo; Laura E Strong; Karolyn A Oetjen; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2002-12-18       Impact factor: 15.419

6.  C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.

Authors:  Carmen P Alvarez; Fátima Lasala; Jaime Carrillo; Oscar Muñiz; Angel L Corbí; Rafael Delgado
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Visualization of Single Multivalent Receptor-Ligand Complexes by Transmission Electron Microscopy The authors thank Colleen Lavin (UW Madison, Microscopy Resource) and Kim Dickson for experimental support. This work was supported in part by the NIH (GM 55984). J.E.G. acknowledges the NIH Biotechnology Training Grant for support (T32GM08349). L.E.S. was supported by an NIH predoctoral fellowship (GM 18750).

Authors:  Jason E. Gestwicki; Laura E. Strong; Laura L. Kiessling
Journal:  Angew Chem Int Ed Engl       Date:  2000-12-15       Impact factor: 15.336

8.  DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection.

Authors:  Douglas S Kwon; Glenn Gregorio; Natacha Bitton; Wayne A Hendrickson; Dan R Littman
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

9.  A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands.

Authors:  D A Mitchell; A J Fadden; K Drickamer
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

10.  Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages.

Authors:  Lars Thiele; Hans P Merkle; Elke Walter
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

View more
  10 in total

1.  Synthetic linear glycopolymers and their biological applications.

Authors:  Qian Qin; Shuyao Lang; Xuefei Huang
Journal:  J Carbohydr Chem       Date:  2021-05-27       Impact factor: 1.667

Review 2.  Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy.

Authors:  Ariel Isser; Natalie K Livingston; Jonathan P Schneck
Journal:  Biomaterials       Date:  2020-12-05       Impact factor: 15.304

3.  Stiffness of HIV-1 Mimicking Polymer Nanoparticles Modulates Ganglioside-Mediated Cellular Uptake and Trafficking.

Authors:  Behnaz Eshaghi; Nourin Alsharif; Xingda An; Hisashi Akiyama; Keith A Brown; Suryaram Gummuluru; Björn M Reinhard
Journal:  Adv Sci (Weinh)       Date:  2020-07-29       Impact factor: 17.521

Review 4.  Seminal Plasma Glycoproteins as Potential Ligands of Lectins Engaged in Immunity Regulation.

Authors:  Beata Olejnik; Mirosława Ferens-Sieczkowska
Journal:  Int J Environ Res Public Health       Date:  2022-08-23       Impact factor: 4.614

Review 5.  Dendritic cell biology and its role in tumor immunotherapy.

Authors:  Yingying Wang; Ying Xiang; Victoria W Xin; Xian-Wang Wang; Xiao-Chun Peng; Xiao-Qin Liu; Dong Wang; Na Li; Jun-Ting Cheng; Yan-Ning Lyv; Shu-Zhong Cui; Zhaowu Ma; Qing Zhang; Hong-Wu Xin
Journal:  J Hematol Oncol       Date:  2020-08-03       Impact factor: 17.388

Review 6.  Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting.

Authors:  Alexey V Baldin; Lyudmila V Savvateeva; Alexandr V Bazhin; Andrey A Zamyatnin
Journal:  Cancers (Basel)       Date:  2020-03-05       Impact factor: 6.639

7.  Synthetic Glycomacromolecules of Defined Valency, Absolute Configuration, and Topology Distinguish between Human Lectins.

Authors:  Manuel Hartweg; Yivan Jiang; Gokhan Yilmaz; Cassie M Jarvis; Hung V-T Nguyen; Gastón A Primo; Alessandra Monaco; Valentin P Beyer; Kathleen K Chen; Somesh Mohapatra; Simon Axelrod; Rafael Gómez-Bombarelli; Laura L Kiessling; C Remzi Becer; Jeremiah A Johnson
Journal:  JACS Au       Date:  2021-08-10

Review 8.  Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases.

Authors:  Giuseppe Stefanetti; Francesco Borriello; Barbara Richichi; Ivan Zanoni; Luigi Lay
Journal:  Front Cell Infect Microbiol       Date:  2022-01-18       Impact factor: 5.293

9.  Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses.

Authors:  Mohammad Murshid Alam; Cassie M Jarvis; Robert Hincapie; Craig S McKay; Jiri Schimer; Carlos A Sanhueza; Ke Xu; Roger C Diehl; M G Finn; Laura L Kiessling
Journal:  ACS Nano       Date:  2020-08-17       Impact factor: 15.881

Review 10.  A molecular understanding of alphavirus entry.

Authors:  Autumn C Holmes; Katherine Basore; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2020-10-22       Impact factor: 7.464

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.